Latest News from: UC Davis Comprehensive Cancer Center

Filters close
Newswise: Can Turmeric Reduce Joint Pain During Breast Cancer Treatment?
Released: 15-Jul-2021 5:05 PM EDT
Can Turmeric Reduce Joint Pain During Breast Cancer Treatment?
UC Davis Comprehensive Cancer Center

The UC Davis Comprehensive Cancer Center received a $50,000 grant from the Safeway Foundation. The funding will allow researcher Mili Arora to study whether the spice turmeric can provide pain relief for breast cancer patients on oral anti-estrogen drugs.

Newswise: Susan G. Komen® Awards $600,000 Research Grant to Radiology Chair Elizabeth Morris
Released: 8-Jul-2021 2:00 PM EDT
Susan G. Komen® Awards $600,000 Research Grant to Radiology Chair Elizabeth Morris
UC Davis Comprehensive Cancer Center

Department of Radiology Chair Elizabeth Morris, with the UC Davis Comprehensive Cancer Center, was awarded a Susan G. Komen® grant to develop artificial intelligence models to predict breast cancer risk at a more personalized level

Newswise: New Medical Director Named to Lead Clinical Cancer Research
Released: 21-Jun-2021 8:00 AM EDT
New Medical Director Named to Lead Clinical Cancer Research
UC Davis Comprehensive Cancer Center

The new medical director for the UC Davis Comprehensive Cancer Center Office of Clinical Research is Dr. Edward Kim who steps into his new position e on July 1, 2021.

Released: 28-Apr-2021 1:35 PM EDT
Male bladder cancer vulnerability could lead to a new treatment approach
UC Davis Comprehensive Cancer Center

UC Davis Comprehensive Cancer Center researchers found that targeting androgen receptors - a type of protein specific to men - may destroy cancer cells. Focusing on this male protein variant common in malignant bladder tumor cells may serve as a new avenue for treating bladder cancer in men.

Released: 23-Apr-2021 2:05 PM EDT
Is raising the sales age of tobacco reducing youth smoking?
UC Davis Comprehensive Cancer Center

A new study, conducted by three UC Davis Comprehensive Cancer Center researchers, studies young adult smoking trends three years after the start of California’s law raising the sales age of tobacco to 21.

Released: 25-Mar-2021 5:45 PM EDT
Catching more breast cancers when mammograms are limited
UC Davis Comprehensive Cancer Center

In one of the largest research projects of its kind, a new study published in JAMA Network Open looks at nearly 900,000 individuals and close to 2 million mammograms to come up with a new way to detect the most breast cancer cases with the fewest exams.

Released: 10-Apr-2020 5:45 PM EDT
California Smokers’ Helpline offers free nicotine patches
UC Davis Comprehensive Cancer Center

Callers to the California Smokers’ Helpline can now get an additional tool to help them quit using tobacco: nicotine patches.

Newswise: Why aren’t advanced bladder cancers being treated?
Released: 20-Jan-2020 9:00 AM EST
Why aren’t advanced bladder cancers being treated?
UC Davis Comprehensive Cancer Center

Despite research showing that aggressive treatment with surgery, chemotherapy and radiation can extend the lives of and even cure patients with advanced bladder cancer, many don’t get it. The result, argues a team led by UC Davis Health urologists, is that the disease for many is still as deadly as it was 30 years ago.

Newswise: Artificial Intelligence Tool Vastly Scales Up Alzheimer's Research
Released: 16-May-2019 10:05 AM EDT
Artificial Intelligence Tool Vastly Scales Up Alzheimer's Research
UC Davis Comprehensive Cancer Center

Researchers at UC Davis Health and UC San Francisco have found a way to teach a computer to detect one of the hallmarks of Alzheimer’s disease

Newswise:Video Embedded prenatal-vitamin-intake-may-reduce-autism-recurrence-in-high-risk-families
VIDEO
25-Feb-2019 12:05 PM EST
Prenatal vitamin intake may reduce autism recurrence in high-risk families
UC Davis Comprehensive Cancer Center

High-risk younger siblings of children with autism are less likely to be diagnosed with autism spectrum disorder (ASD), have significantly lower autism symptom severity, and higher cognitive scores if their mothers take maternal prenatal vitamins during their first month of pregnancy, UC Davis research has found.

Newswise: Radiologists quickly improve screening performance with 3D mammography
22-Feb-2019 6:05 PM EST
Radiologists quickly improve screening performance with 3D mammography
UC Davis Comprehensive Cancer Center

Radiologists quickly learn to read 3D mammography more accurately than they read standard 2D mammograms, a first-of-its-kind study by a UC Davis researcher has found. Published today in Radiology, the study led by Diana Miglioretti, UC Davis dean’s professor of biostatistics, found that radiologists who interpret traditional mammograms, which are two-dimensional, required little start up time for transitioning to reading digital breast tomosynthesis (DBT), or 3D mammography, with improved screening accuracy

Newswise: Early Intervention in Autism Improves Language, IQ and Social Skills
Released: 4-Feb-2019 8:05 AM EST
Early Intervention in Autism Improves Language, IQ and Social Skills
UC Davis Comprehensive Cancer Center

Breakthrough research demonstrating that children with autism as young as 18 months can vastly improve their language, cognition and social skills with an early intervention developed by UC Davis Professor Sally Rogers has been replicated in a major new study.

Newswise:Video Embedded autism,-adhd-and-their-risks-for-siblings
VIDEO
Released: 11-Dec-2018 2:05 PM EST
Autism, ADHD and their risks for siblings
UC Davis Comprehensive Cancer Center

Dr. Meghan Miller of the UC Davis MIND Institute talks about her paper, published in JAMA Pediatrics, about the risk of younger siblings of children with autism or ADHD for either or both disorders.

Newswise:Video Embedded obesity-both-feeds-tumors-and-helps-immunotherapy-kill-cancer
VIDEO
7-Nov-2018 12:05 PM EST
Obesity both feeds tumors and helps immunotherapy kill cancer
UC Davis Comprehensive Cancer Center

A groundbreaking new study by UC Davis researchers has uncovered why obesity both fuels cancer growth and allows blockbuster new immunotherapies to work better against those same tumors. The paradoxical findings, published today in Nature Medicine, give cancer doctors important new information when choosing drugs and other treatments for cancer patients.

Newswise: Study seeks to improve cancer survival for Latinos, Asians and Blacks
Released: 21-Sep-2018 5:05 PM EDT
Study seeks to improve cancer survival for Latinos, Asians and Blacks
UC Davis Comprehensive Cancer Center

UC Davis Comprehensive Cancer Center has received a $6.3 million grant from the National Cancer Institute’s (NCI) Center to Reduce Cancer Health Disparities for a 5-year study to tease out why some ethnic and racial minority groups fare worse than whites when they get cancer and to find more precise treatments to improve their chances of survival.

Newswise: Research Informs New National Cervical Cancer Screening Recommendation
16-Aug-2018 2:00 PM EDT
Research Informs New National Cervical Cancer Screening Recommendation
UC Davis Comprehensive Cancer Center

A comprehensive analysis of eight clinical trials and four cohort studies on cervical cancer screening by researchers from UC Davis and Kaiser Permanente Northwest has found that while Pap smears are still highly effective for detecting pre-cancerous cells and cancer, testing for the virus that causes these cancers also is an excellent screening tool.

Newswise: Liquid Biopsy Could Ease the Way to Immunotherapy for Lung Cancer
Released: 6-Aug-2018 11:05 AM EDT
Liquid Biopsy Could Ease the Way to Immunotherapy for Lung Cancer
UC Davis Comprehensive Cancer Center

Researchers at UC Davis, Genentech and Foundation Medicine are the first to show that a blood-based test to assess tumor mutational burden (TMB) accurately identifies non-small cell lung cancer (NSCLC) patients who could benefit from immunotherapies called checkpoint inhibitors. The blood test offers a much less invasive and more repeatable alternative to tissue testing. The study was published online today in Nature Medicine.

Newswise: The Surge in Throat Cancer, Especially in Men
Released: 31-Jul-2018 6:05 PM EDT
The Surge in Throat Cancer, Especially in Men
UC Davis Comprehensive Cancer Center

Humanpapilloma virus (HPV) is now the leading cause of certain types of throat cancer. Dr. Michael Moore, director of head and neck surgery at UC Davis and an HPV-related cancer expert, answers some tough questions about the trend and what can be done about it.

Newswise: Stem Cell Transplants Extend Life for Multiple Myeloma Patients
Released: 12-Jun-2018 2:05 PM EDT
Stem Cell Transplants Extend Life for Multiple Myeloma Patients
UC Davis Comprehensive Cancer Center

Researchers at UC Davis have confirmed that autologous hematopoietic stem cell transplant improves survival for people suffering from multiple myeloma, yet many potentially eligible patients never undergo the procedure.

Newswise: Acute Myeloid Leukemia Patients Have Reduced Early Mortality at NCI-Designated Cancer Centers
Released: 8-Mar-2018 3:30 PM EST
Acute Myeloid Leukemia Patients Have Reduced Early Mortality at NCI-Designated Cancer Centers
UC Davis Comprehensive Cancer Center

Researchers at UC Davis have shown that patients with acute myeloid leukemia (AML) who received their care at a National Cancer Institute (NCI) cancer center in California had a dramatically reduced risk of early mortality. Using data from the California Cancer Registry and the Patient Discharge Dataset, the team determined that the risk was reduced by 53 percent. These findings were reported in February in the journal Cancer.

Released: 14-Feb-2018 4:00 PM EST
There’s an App for That
UC Davis Comprehensive Cancer Center

UC Davis pathologist Hooman Rashidi is an expert in blood disorders but also a computer programmer. He has married the two disciplines and created must-have learning tools for medical students and residents. His latest is HemeQuiz1, a medical student training app.

Newswise: UC Davis Researcher Urges Caution on Engineered Stem Cells
Released: 3-Jan-2018 5:05 PM EST
UC Davis Researcher Urges Caution on Engineered Stem Cells
UC Davis Comprehensive Cancer Center

In a commentary published in the Jan. 4 issue of the New England Journal of Medicine, UC Davis researcher William Murphy expressed cautious optimism about efforts to genetically engineer hematopoietic stem cells (HSCs) to temporarily resist cell death during transplantation. While these gene therapy approaches could dramatically improve patient outcomes, Murphy argues that their risks must be carefully studied in diverse models.

Newswise: Unlocking the Genetics of Cancer
Released: 28-Nov-2017 3:05 PM EST
Unlocking the Genetics of Cancer
UC Davis Comprehensive Cancer Center

For many, breast cancer is more than just a disease – it’s personal. One in eight women will be diagnosed with breast cancer at some point in their lives.

Newswise: The Understudied Consequences of Peripheral Neuropathy after Chemotherapy
Released: 29-Aug-2017 8:05 AM EDT
The Understudied Consequences of Peripheral Neuropathy after Chemotherapy
UC Davis Comprehensive Cancer Center

In two papers published in the Journal of the National Cancer Institute researchers from UC Davis, UCLA and other institutions have found that peripheral neuropathy, which causes pain, numbness, and tingling in hands and/or feet, can bother early-stage breast cancer patients years after completing chemotherapy. In addition, a systematic literature review found only a handful of studies that tracked long-term peripheral neuropathy, leaving little data for patients and clinicians to make informed decisions.

Newswise: UC Davis-Led Group Receives $17 Million in NCI Funds
Released: 19-Jul-2017 6:05 PM EDT
UC Davis-Led Group Receives $17 Million in NCI Funds
UC Davis Comprehensive Cancer Center

Breast Cancer Surveillance Consortium (BCSC) investigators have received a $17 million program project grant renewal from the National Cancer Institute to study the effectiveness of different breast cancer screening and surveillance strategies using digital mammography, digital breast tomosynthesis (3D mammography), and breast MRI. Co-led by UC Davis researcher Diana Miglioretti, the consortium seeks to ensure that women get personalized care based on their individual risk and preferences.

Newswise:Video Embedded how-treating-a-dog-s-tumors-may-help-in-the-fight-against-human-cancer
VIDEO
Released: 6-Jul-2017 2:00 PM EDT
How Treating a Dog's Tumors May Help in the Fight Against Human Cancer
UC Davis Comprehensive Cancer Center

With its internationally renowned school of veterinary medicine and its NCI-designated comprehensive cancer center, UC Davis is uniquely positioned to harness the power of each to tackle one of life’s greatest challenges: cancer.

Newswise: Second Cancers Deadlier in Young Patients
18-Apr-2017 2:00 PM EDT
Second Cancers Deadlier in Young Patients
UC Davis Comprehensive Cancer Center

Second cancers in children and adolescents and young adults (AYA) are far deadlier than they are in older adults and may partially account for the relatively poor outcomes of cancer patients ages 15-39 overall, a new study by UC Davis researchers has found."Second Primary Malignant Neoplasms and Survival in Adolescent and Adult Cancer Survivors" is published today in JAMA Oncology.

Newswise: Hitting Cancer with High-Intensity Ultrasound and Immunotherapy
Released: 23-Mar-2017 3:05 PM EDT
Hitting Cancer with High-Intensity Ultrasound and Immunotherapy
UC Davis Comprehensive Cancer Center

In a new study published today in JCI Insight, UC Davis researchers have shown that combining high-intensity focused ultrasound with two immunotherapies (a PD-1 checkpoint inhibitor and TLR9 agonist) can produce excellent response rates in mouse models of epithelial cancer. They also found that, for the combination to be effective, immunotherapies must come first.

Newswise: UC Davis and Nation's Cancer Centers Jointly Endorse Updated HPV Vaccine Recommendations
Released: 17-Jan-2017 2:05 PM EST
UC Davis and Nation's Cancer Centers Jointly Endorse Updated HPV Vaccine Recommendations
UC Davis Comprehensive Cancer Center

Recognizing a critical need to improve national vaccination rates for the human papillomavirus (HPV), UC Davis Comprehensive Cancer Center has again united with each of the 69 National Cancer Institute (NCI)-designated cancer centers in issuing a joint statement in support of recently revised recommendations from the U.S. Centers for Disease Control and Prevention (CDC)

Newswise: Terminally Ill Cancer Patients Fare Poorly After Surgery
24-Oct-2016 4:05 PM EDT
Terminally Ill Cancer Patients Fare Poorly After Surgery
UC Davis Comprehensive Cancer Center

Patients with disseminated advanced cancer who undergo surgery are far more likely to endure long hospital stays and readmissions, referrals to extended care facilities and death, UC Davis researchers have found.

Newswise: Sexual Pain in Women After Cancer Is Common, and Too Often Ignored
Released: 24-Oct-2016 3:05 PM EDT
Sexual Pain in Women After Cancer Is Common, and Too Often Ignored
UC Davis Comprehensive Cancer Center

Painful sex in women after cancer treatment is relatively common, often treatable and needs to be addressed by medical providers, a UC Davis oncologist and researcher suggests.

Newswise: Lay Educators Help Boost Colorectal Screening Rates in Hmong
26-Aug-2016 9:00 AM EDT
Lay Educators Help Boost Colorectal Screening Rates in Hmong
UC Davis Comprehensive Cancer Center

Hmong Americans are more likely to understand the importance of colorectal cancer screening and to get screened when they’re provided information by specially trained Hmong lay health educators, new research from UC Davis has found.

Released: 28-Jul-2016 2:05 PM EDT
Hybrid Treatment Hunts Down and Kills Leukemia Cells
UC Davis Comprehensive Cancer Center

Researchers at UC Davis and Ionis Pharmaceuticals have developed a hybrid treatment that harnesses a monoclonal antibody to deliver antisense DNA to acute lymphoblastic leukemia (ALL) cells and that may lead to less toxic treatments for the disease.

Released: 25-May-2016 4:05 PM EDT
Miglioretti Awarded $7.5 Million to Evaluate Supplemental Breast Imaging
UC Davis Comprehensive Cancer Center

Diana Miglioretti, UC Davis dean’s professor of biostatistics and an internationally recognized breast cancer screening expert, has received $7.5 million to determine the effectiveness of two supplemental breast screening and diagnostic workup strategies -- digital breast tomosynthesis (3D mammography) and magnetic resonance imaging (MRI) -- used with mammography for cancer detection. Miglioretti’s team also will work to determine whether effectiveness of the screening strategies depends on a woman’s breast density.

Released: 2-May-2016 2:05 PM EDT
Common Supplement Boosts Kidney Cancer Therapy
UC Davis Comprehensive Cancer Center

Researchers at UC Davis have shown that docosahexaenoic acid (DHA), a fatty acid commonly found in fish and fish oil supplements, reduces renal cell carcinoma invasiveness, growth rate, and blood vessel growth when combined with the anti-cancer therapy regorafenib. The study was published in the May issue of the journal Molecular Cancer Therapeutics.

Newswise: Targeted Hepatitis B Virus Screening Effective in Addressing Infection, Liver Disease Risk
Released: 2-May-2016 2:05 PM EDT
Targeted Hepatitis B Virus Screening Effective in Addressing Infection, Liver Disease Risk
UC Davis Comprehensive Cancer Center

A community-based hepatitis B virus screening effort led by UC Davis researchers found that targeted outreach to Asian American populations can identify groups at high risk for infection and direct them to appropriate follow-up care to help prevent the onset of liver diseases, including cancer.

Newswise: Radiation Improves Survival in Older Patients with Soft Tissue Sarcomas
Released: 11-Apr-2016 11:05 AM EDT
Radiation Improves Survival in Older Patients with Soft Tissue Sarcomas
UC Davis Comprehensive Cancer Center

UC Davis researchers have shown that radiation therapy following surgery benefits older patients more than their younger counterparts, a surprising finding that could change the way some patients are treated for soft tissue sarcomas (STS). Also, the photo upload is not working. I'll send by email.

Newswise:
Released: 15-Mar-2016 11:05 AM EDT
"Coloring Therapy" Helps Ease Patients' Stress
UC Davis Comprehensive Cancer Center

Coloring provides a quiet respite at the UC Davis Comprehensive Cancer Center.

Newswise: Young, Poor African Americans and Hispanics Have Harder Time Beating Hodgkin Lymphoma
Released: 29-Jan-2016 11:05 AM EST
Young, Poor African Americans and Hispanics Have Harder Time Beating Hodgkin Lymphoma
UC Davis Comprehensive Cancer Center

African American and Hispanic adolescents and young adults fare far worse than their white counterparts when faced with a mostly curable type of cancer, Hodgkin lymphoma, a study by a UC Davis epidemiologist has found

6-Jan-2016 2:05 PM EST
Making a Safe Procedure Even Safer
UC Davis Comprehensive Cancer Center

In a comprehensive modeling study, researchers from UC Davis and other institutions have found that breast cancer screening with digital mammography poses only a small risk of radiation-induced breast cancer for most women. However, the research showed increased risk for women with large breasts or breast implants, who must often receive extra screening views, increasing their radiation exposure.

6-Jan-2016 4:05 PM EST
More Research Needed on Evaluation of Dense Breasts
UC Davis Comprehensive Cancer Center

A systematic review of the scientific literature on dense breasts by researchers at UC Davis and other institutions has found that determinations of breast density can be unreliable and that as many as 19 percent of women are re-categorized as dense rather than non-dense or vice versa from one mammogram to the next. The study also found that supplemental diagnostic screenings for women with dense breasts find additional breast cancers but also greatly increase false positive results.

Newswise: A Visit to the Gas Station: Protein Helps Power up DNA Repair
24-Nov-2015 9:05 AM EST
A Visit to the Gas Station: Protein Helps Power up DNA Repair
UC Davis Comprehensive Cancer Center

In a game-changing study, researchers at UC Davis and other organizations have shown that the enzyme cyclin-dependent kinase 1 (CDK1), which plays a key role in DNA repair, also leaves the nucleus to boost cellular energy production. By irradiating normal cells, the team showed that CDK1 turned up production of ATP, cellular energy packets that – in this case – provided the necessary power supply to fix the radiation-damaged DNA.

Newswise: Small RNA has Big Impact on Prostate Cancer
Released: 17-Nov-2015 8:00 AM EST
Small RNA has Big Impact on Prostate Cancer
UC Davis Comprehensive Cancer Center

Researchers at the UC Davis Comprehensive Cancer Center have shown that the microRNA, miR-124, reduced tumor growth and increased cell death in castration-resistant prostate cancer. This small RNA fragment hit multiple targets, reducing androgen receptor signaling and reviving the potency of enzalutamide, a treatment for advanced prostate cancer. In addition, miR-124 impeded EZH2 and Src, proteins that contribute to treatment resistance. The research was published online Monday in Cancer Research.

Newswise:/images/icons/audio_thumb_100x75.png
AUDIO
15-Oct-2015 2:00 PM EDT
Menopausal Status a Better Indicator Than Age for Mammography Frequency
UC Davis Comprehensive Cancer Center

In a study conducted to inform American Cancer Society (ACS) breast cancer screening guidelines, UC Davis researcher Diana L. Miglioretti reports a screening mammogram once every two years is safe for postmenopausal women at average risk of breast cancer.

Newswise:Video Embedded uc-davis-granted-15-5-million-to-build-world-s-first-total-body-pet-scanner
VIDEO
6-Oct-2015 10:00 AM EDT
UC Davis Granted $15.5 Million to Build World’s First Total-Body PET Scanner
UC Davis Comprehensive Cancer Center

A UC Davis research team has been awarded $15.5 million to build the world’s first total-body positron emission tomography (PET) scanner, which could fundamentally change the way cancers are tracked and treated and put the university on the nation’s leading edge of molecular imaging.


Showing results

150 of 96

close
0.31405